Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease modelYoshikazu Tasaki(Asahikawa Medical University), Kazuo Matsubara(Kyoto University Hospital)Neuroscience LettersMay 22, 201210.1016/j.neulet.2012.05.045Cited by 25SaveCiteExport RISWatch citationsRelated PapersOxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity|European Journal of Pharmacology|2011|22Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells|PLoS ONE|2015|6